EP2836595
Samsetningar og aðferðir til að hindra tjáningu á ALAS1 geninu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.4.2013EP published:
14.6.2017EP application number:
13721433.4
EP translation filed:
4.9.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
9.4.2033Expiry date:
9.4.2027Next due date:
30.4.2027
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
Timeline
Today
10.4.2013EP application
14.6.2017EP Publication
4.9.2017Translation submitted
15.9.2017Registration published
9.4.2027Expires
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
300 Third Street, 02142, Cambridge, MA, US
Name:
Icahn School of Medicine at Mount SinaiAddress:
One Gustave L. Levy Place, 10029, New York, NY, US
Inventor
Name:
BETTENCOURT, BrianAddress:
Cambridge, MA, US
Name:
FITZGERALD, KevinAddress:
Brookline, MA, US
Name:
QUERBES, WilliamAddress:
Cambridge, MA, US
Name:
YASUDA, MakikoAddress:
New York, NY, US
Name:
DESNICK, Robert, J.Address:
New York, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261622288 PDate:
10.4.2012Country:
US
Number:
201313835613Date:
15.3.2013Country:
US
Classification
Categories:
C12N 15/113, A61K 31/713, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 20.3.2018
Expires: 9.4.2019
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 19.3.2019
Expires: 9.4.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.3.2020
Expires: 9.4.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 18.3.2021
Expires: 9.4.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 21.3.2022
Expires: 9.4.2023
Payer: Patice ehf.
Number: 11
Paid: 21.3.2023
Expires: 9.4.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 19.3.2024
Expires: 9.4.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.4.2025
Expires: 9.4.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.4.2026
Expires: 9.4.2027
Payer: Árnason Faktor ehf.